Related Experiment Video
Updated: May 22, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Regulatory interplay between miR-21, JAG1 and 17beta-estradiol (E2) in breast cancer cells
S Duygu Selcuklu1, Mark T A Donoghue, Michael J Kerin
1Genetics and Biotechnology Lab, Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Abstract:
Overexpression of the oncomir miR-21 is associated with many cancers, including breast cancer. Elevated levels of Jagged-1 (JAG1), a predicted miR-21 target, are implicated in estrogen receptor negative (ER-) breast cancer. We demonstrate (by ablation of the miR-21 binding site in the JAG1 3'UTR) that miR-21 directly targets and represses JAG1 levels in MCF-7 (ER+) breast cancer cells. MiR-21 targeting of JAG1 in MDA-MB-231 (ER-) breast cancer cells is dependent on miR-21 dosage (levels). In both cell lines, miR-21 and JAG1 expression levels were negatively correlated due to their regulatory relationship. In addition, 17beta-estradiol (E2) increases JAG1 levels by limiting (via downregulating miR-21 levels) the repressive effects of miR-21 on the JAG1 3'UTR. Our results reveal a regulatory interplay between miR-21, JAG1 and E2 that is important for advancing understanding of how the oncogenic potential of miR-21 and JAG1 manifests in different sub-types of breast cancer.
Insights
MicroRNA-21 (miR-21) directly targets Jagged-1 (JAG1), impacting breast cancer progression. Estrogen influences this interaction, revealing a complex regulatory network in different breast cancer subtypes.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Overexpression of the oncomir miR-21 is linked to various cancers, including breast cancer.
- Elevated Jagged-1 (JAG1) levels are implicated in estrogen receptor-negative (ER-) breast cancer, and JAG1 is a predicted target of miR-21.
Purpose of the Study:
- To investigate the regulatory relationship between miR-21 and JAG1 in different breast cancer subtypes.
- To elucidate the role of 17beta-estradiol (E2) in modulating the miR-21/JAG1 interaction.
Main Methods:
- Demonstrated direct targeting of JAG1 by miR-21 via ablation of the miR-21 binding site in the JAG1 3'UTR in MCF-7 (ER+) cells.
- Assessed miR-21 targeting of JAG1 in MDA-MB-231 (ER-) cells, noting its dependence on miR-21 dosage.
- Analyzed the correlation between miR-21 and JAG1 expression levels and the effect of E2 on JAG1 levels.
Main Results:
- miR-21 directly targets and represses JAG1 in ER+ breast cancer cells (MCF-7).
- miR-21 targeting of JAG1 in ER- breast cancer cells (MDA-MB-231) is dosage-dependent.
- miR-21 and JAG1 expression levels were negatively correlated in both cell lines.
- 17beta-estradiol (E2) increases JAG1 levels by downregulating miR-21, thereby reducing miR-21's repressive effect on the JAG1 3'UTR.
Conclusions:
- A regulatory interplay exists between miR-21, JAG1, and E2 in breast cancer.
- This interaction is crucial for understanding the oncogenic roles of miR-21 and JAG1 in distinct breast cancer subtypes.
- Findings contribute to understanding breast cancer pathogenesis and potential therapeutic targets.
Related Concept Videos
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
MicroRNAs
MicroRNAs
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

